SOURCE: Solos Endoscopy, Inc.

January 18, 2007 08:31 ET

Solos Endoscopy, Inc. Appoints Former Xomed Surgical International Sales Director as Vice President of International Sales

BOSTON, MA -- (MARKET WIRE) -- January 18, 2007 -- Solos Endoscopy, Inc. (PINKSHEETS: SLSY) is pleased to announce the selection of Joseph N. Gassman as Vice President of International Sales. The position is pivotal in the Company's efforts to expand its presence in the European market. Mr. Gassman has 30 years of sales and management experience in the medical industry and has focused particularly on medical devices, covering both capital equipment and disposable surgical products.

Mr. Gassman helped build the international distribution network for Merocel Corporation, which later acquired Xomed Surgical and his attention then turned to building the international operations for the combined companies. Mr. Gassman has been with the First Aid Bandage Company (FABCO) since 2003, where he was responsible for developing FABCO's international sales and distributor network, product training courses, and educational support materials. Prior to his stint with FABCO, Mr. Gassman held the position of International Sales and Marketing Director for M-Pact Corp. - Surgical Products Division, where he built an international distribution base, spanning 48 countries, from his office in Mainz, Germany. During his career, Mr. Gassman has been International Sales Director for Rudolph Beaver, Inc., a division of Becton Dickinson, Cooper Medical/Cooper Vision Systems, Inc. and Clinitex, a division of Varian Corp.

"As we move forward with our strategy to expand into the international medical marketplace, Mr. Gassman's knowledge and professionalism will be extremely beneficial to us. With his networking abilities and extensive experience in the international medical device market, we feel his talents will greatly enable us to expand our global presence," stated Robert Segersten, President of Solos Endoscopy, Inc.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician's office. Additional information is available on the Company's website at: www.solosendoscopy.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Contact Information

  • Contact:
    For Solos Endoscopy, Inc.
    Investor Relations
    1-866-THE-APPL(E)